KMWM
GILD icon

Keudell/Morrison Wealth Management’s Gilead Sciences GILD Stock Holding History

Keudell/Morrison Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
14,835
-181
-1% -$23.8K 0.35% 49
2026
Q1 		$2.09M Sell
15,016
-1,006
-6% -$141K 0.43% 40
2025
Q4 		$1.97M Buy
+16,022
New +$1.95M 0.41% 41
2025
Q2 		$545K Sell
4,919
-2,106
-30% -$224K 0.12% 114
2025
Q1 		$787K Sell
7,025
-1,165
-14% -$120K 0.19% 78
2024
Q4 		$757K Sell
8,190
-567
-6% -$51.1K 0.2% 81
2024
Q3 		$734K Sell
8,757
-107
-1% -$8.16K 0.2% 88
2024
Q2 		$608K Buy
8,864
+12
+0.1% +$801 0.18% 98
2024
Q1 		$648K Buy
8,852
+1,794
+25% +$138K 0.2% 94
2023
Q4 		$572K Sell
7,058
-659
-9% -$51.3K 0.19% 96
2023
Q3 		$578K Buy
7,717
+664
+9% +$51.1K 0.18% 87
2023
Q2 		$544K Sell
7,053
-1,359
-16% -$108K 0.16% 98
2023
Q1 		$698K Sell
8,412
-3,622
-30% -$300K 0.21% 83
2022
Q4 		$1.03M Sell
12,034
-1,577
-12% -$125K 0.33% 53
2022
Q3 		$840K Buy
13,611
+185
+1% +$11.7K 0.31% 61
2022
Q2 		$830K Buy
13,426
+1,559
+13% +$96.5K 0.3% 70
2022
Q1 		$705K Buy
11,867
+2,435
+26% +$156K 0.29% 79
2021
Q4 		$685K Sell
9,432
-1,295
-12% -$89.2K 0.27% 79
2021
Q3 		$749K Buy
10,727
+458
+4% +$32.2K 0.32% 75
2021
Q2 		$707K Buy
10,269
+220
+2% +$14.7K 0.39% 76
2021
Q1 		$649K Buy
10,049
+1,007
+11% +$64.9K 0.38% 79
2020
Q4 		$527K Buy
9,042
+1,380
+18% +$83.3K 0.33% 87
2020
Q3 		$484K Buy
7,662
+3,113
+68% +$216K 0.31% 84
2020
Q2 		$350K Sell
4,549
-4,203
-48% -$322K 0.29% 98
2020
Q1 		$654K Buy
8,752
+120
+1% +$8.29K 0.64% 57
2019
Q4 		$561K Buy
8,632
+888
+11% +$57.8K 0.39% 76
2019
Q3 		$491K Buy
7,744
+2,172
+39% +$142K 0.41% 77
2019
Q2 		$356K Buy
5,572
+2,488
+81% +$164K 0.31% 90
2019
Q1 		$200K Buy
+3,084
New +$205K 0.18% 129

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Keudell/Morrison Wealth Management's GILD Position: Q2 2026 in Review

Keudell/Morrison Wealth Management reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $23.8K and leaving 14,835 shares worth $1.87M. The position accounts for 0.35% of the portfolio, ranked #49.

Keudell/Morrison Wealth Management first reported a position in GILD in Q1 2019 and has held it in 29 quarters since. The position peaked at $2.09M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Keudell/Morrison Wealth Management held 14,835 shares of Gilead Sciences worth $1.87M as of Q2 2026.
  • Keudell/Morrison Wealth Management sold 181 Gilead Sciences shares in Q2 2026, an estimated $23.8K.
  • Gilead Sciences made up 0.35% of Keudell/Morrison Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Keudell/Morrison Wealth Management first reported a position in Gilead Sciences in Q1 2019 and has held it in 29 quarters since.
  • Keudell/Morrison Wealth Management's Gilead Sciences position peaked at $2.09M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Keudell/Morrison Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.